Clinical Trial Update: Penn Microbiome Therapy for Recurrent Clostridium Difficile Infection [Phase 2]

View source ↗

Summary

Phase 2 trial update for Penn microbiome therapy targeting recurrent Clostridioides difficile infection; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Penn microbiome therapy

Snippet

Sponsor: University of Pennsylvania | Conditions: Recurrent Clostridium Difficile Infection | Phase 2 | Status: TERMINATED | Results posted: 2023-11-01